These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

922 related items for PubMed ID: 33492661

  • 1. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
    Gunaratnam S, Diarra C, Paquette PD, Ship N, Millette M, Lacroix M.
    Probiotics Antimicrob Proteins; 2021 Aug; 13(4):949-956. PubMed ID: 33492661
    [Abstract] [Full Text] [Related]

  • 2. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection.
    Auclair J, Frappier M, Millette M.
    Clin Infect Dis; 2015 May 15; 60 Suppl 2():S135-43. PubMed ID: 25922399
    [Abstract] [Full Text] [Related]

  • 3. Transcriptome analysis of the Clostridioides difficile response to a specific lactobacilli probiotic formulation: explanations for its mechanisms of action.
    Masset Z, Gunaratnam S, Millette M, McFarland LV, Lacroix M.
    J Appl Microbiol; 2023 Mar 01; 134(3):. PubMed ID: 36898672
    [Abstract] [Full Text] [Related]

  • 4. A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).
    Maziade PJ, Pereira P, Goldstein EJ.
    Clin Infect Dis; 2015 May 15; 60 Suppl 2():S144-7. PubMed ID: 25922400
    [Abstract] [Full Text] [Related]

  • 5. Probiotics and prevention of Clostridium difficile infection.
    Goldstein EJC, Johnson SJ, Maziade PJ, Evans CT, Sniffen JC, Millette M, McFarland LV.
    Anaerobe; 2017 Jun 15; 45():114-119. PubMed ID: 27988389
    [Abstract] [Full Text] [Related]

  • 6. Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence.
    McFarland LV, Ship N, Auclair J, Millette M.
    J Hosp Infect; 2018 Aug 15; 99(4):443-452. PubMed ID: 29702133
    [Abstract] [Full Text] [Related]

  • 7. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients.
    Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE.
    Am J Gastroenterol; 2010 Jul 15; 105(7):1636-41. PubMed ID: 20145608
    [Abstract] [Full Text] [Related]

  • 8. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
    Preston K, Krumian R, Hattner J, de Montigny D, Stewart M, Gaddam S.
    Benef Microbes; 2018 Sep 18; 9(5):697-706. PubMed ID: 29888656
    [Abstract] [Full Text] [Related]

  • 9. The Probiotic Strain Lactobacillus acidophilus CL1285 Reduces Fat Deposition and Oxidative Stress and Increases Lifespan in Caenorhabditis elegans.
    Bouasker S, Nodland S, Millette M.
    Microorganisms; 2024 May 21; 12(6):. PubMed ID: 38930418
    [Abstract] [Full Text] [Related]

  • 10. Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells.
    Boonma P, Spinler JK, Venable SF, Versalovic J, Tumwasorn S.
    BMC Microbiol; 2014 Jul 02; 14():177. PubMed ID: 24989059
    [Abstract] [Full Text] [Related]

  • 11. Implementation strategies for hospital-based probiotic administration in a stepped-wedge cluster randomized trial design for preventing hospital-acquired Clostridioides difficile infection.
    Bresee LC, Lamont N, Ocampo W, Holroyd-Leduc J, Sabuda D, Leal J, Dalton B, Kaufman J, Missaghi B, Kim J, Larios OE, Henderson E, Raman M, Fletcher JR, Faris P, Kraft S, Shen Y, Louie T, Conly JM.
    BMC Health Serv Res; 2023 Dec 11; 23(1):1386. PubMed ID: 38082421
    [Abstract] [Full Text] [Related]

  • 12. Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly.
    Lahtinen SJ, Forssten S, Aakko J, Granlund L, Rautonen N, Salminen S, Viitanen M, Ouwehand AC.
    Age (Dordr); 2012 Feb 11; 34(1):133-43. PubMed ID: 21264685
    [Abstract] [Full Text] [Related]

  • 13. The synergistic effect of cell wall extracted from probiotic biomass containing Lactobacillus acidophilus CL1285, L. casei LBC80R, and L. rhamnosus CLR2 on the anticancer activity of cranberry juice-HPLC fractions.
    Desrouillères K, Millette M, Bagheri L, Maherani B, Jamshidian M, Lacroix M.
    J Food Biochem; 2020 May 11; 44(5):e13195. PubMed ID: 32185816
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of Bio-K+ for the prevention of Clostridioides difficile infection: Stepped-wedge cluster-randomized controlled trial.
    Leal J, Shen Y, Faris P, Dalton B, Sabuda D, Ocampo W, Bresee L, Chow B, Fletcher JR, Henderson E, Kaufman J, Kim J, Raman M, Kraft S, Lamont NC, Larios O, Missaghi B, Holroyd-Leduc J, Louie T, Conly J.
    Infect Control Hosp Epidemiol; 2024 Apr 11; 45(4):443-451. PubMed ID: 38073551
    [Abstract] [Full Text] [Related]

  • 15. Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital.
    Maziade PJ, Andriessen JA, Pereira P, Currie B, Goldstein EJ.
    Curr Med Res Opin; 2013 Oct 11; 29(10):1341-7. PubMed ID: 23931498
    [Abstract] [Full Text] [Related]

  • 16. [Influence of selected Lactobacillus sp. on Clostridium difficile strains with different toxigenicity profile].
    Wultańska D, Pituch H, Obuch-Woszczatyński P, Meisel-Mikołajczyk F, Luczak M.
    Med Dosw Mikrobiol; 2006 Oct 11; 58(2):127-33. PubMed ID: 17133906
    [Abstract] [Full Text] [Related]

  • 17. Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia.
    Aroutcheva A, Auclair J, Frappier M, Millette M, Lolans K, de Montigny D, Carrière S, Sokalski S, Trick WE, Weinstein RA.
    Probiotics Antimicrob Proteins; 2016 Mar 11; 8(1):31-40. PubMed ID: 26915093
    [Abstract] [Full Text] [Related]

  • 18. A potential therapeutic strategy of an innovative probiotic formulation toward topical treatment of diabetic ulcer: an in vivo study.
    Karimi F, Montazeri-Najafabady N, Mohammadi F, Azadi A, Koohpeyma F, Gholami A.
    Nutr Diabetes; 2024 Aug 20; 14(1):66. PubMed ID: 39164243
    [Abstract] [Full Text] [Related]

  • 19. Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.
    McFarland LV, Evans CT, Goldstein EJC.
    Front Med (Lausanne); 2018 Aug 20; 5():124. PubMed ID: 29868585
    [Abstract] [Full Text] [Related]

  • 20. Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: is it due to synergies in probiotic mixtures or the specificity of single strains?
    Tejero-Sariñena S, Barlow J, Costabile A, Gibson GR, Rowland I.
    Anaerobe; 2013 Dec 20; 24():60-5. PubMed ID: 24091275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.